Skip to main content

JHOP - March 2025 Vol 15 Special Feature

DOWNLOAD EDITORIAL PDF

Download Hopa Abstracts PDF

Editorial
HOPA Abstracts
Editorial
Editorial
Finding Hope in a New Year of HOPA Annual Conference Research Abstracts
Adam J. DiPippo, PharmD, BCOP; Courtney C. Cavalieri, PharmD, BCOP
Read More
HOPA Abstracts
HOPA Abstracts
Optimizing Iron Dextran Infusion Protocols to Enhance Efficiency and Patient Throughput in an Outpatient Infusion Center: A Process Improvement Initiative
Abstract #CR01
Minhee Kang, PharmD, BCPS, BCOP; Richard Verstraete, RN
Read More
HOPA Abstracts
Characteristics and Dosing Patterns of US Patients Diagnosed With HR-Positive/HER2-Negative Early Breast Cancer Initiating Abemaciclib at a Lower Dose Than the Approved 150 mg Twice Daily
Abstract #CR02
Andrea LeVoir, PharmD; Laura Spring, MD; Wambui Gathirua-Mwangi, PhD; Sangmi Kim, PhD; Zhanglin Lin Cui, PhD; Samuel Whipple, MPH, et al.
Read More
HOPA Abstracts
Clinical Characteristics and Treatment Persistence in US Patients With HR-Positive/HER2-Negative, Node-Positive Early Breast Cancer Treated With Abemaciclib: Real-World Study From First Year After Approval
Abstract #CR03
Erich Brechtelsbauer, PharmD, MS; Kathryn Hudson, MD; Wambui Gathirua-Mwangi, PhD; Zhanglin Lin Cui; Brenda Grimes, PhD; Astra M. Liepa, PharmD, et al.
Read More
HOPA Abstracts
Clinical Outcomes of 2-Dose Tandem Influenza Vaccination Strategy in Patients With Plasma Cell Dyscrasias
Abstract #CR04
E. Bridget Kim, PharmD, BCPS, BCOP; Jack Malespini, PharmD, BCOP; Victoria Yeung; Brenna Rowen, PharmD, BCOP; Jennifer A. Hutchinson, PharmD
Read More
HOPA Abstracts
Dexamethasone Versus Tocilizumab for Management of Cytokine Release Syndrome Related to Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma
Abstract #CR05
James A. Davis, PharmD, BCOP; Katelynn Granger, PharmD; Kimberly M. Green, DO; Jordan Snyder, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA; Mikhaila Rice, PharmD, BCOP, et al.
Read More
HOPA Abstracts
Evaluating the Impact of Interactive Ambulatory Care Discussions at an Oncology Center
Abstract #CR06
Abigail Shockley, PharmD, BCOP; JP Sanchez, PharmD, BCOP; Todd W. Canada, PharmD, BCNSP, BCCCP, FASHP, FTSHP, FASPEN
Read More
HOPA Abstracts
Evaluation of a Decentralized Infusion Pharmacist in an Oncology Infusion Clinic of an Academic Medical Center
Abstract #CR07
Sarah Castelo, PharmD, BCOP; Nick Hopkins, PharmD, BCSCP
Read More
HOPA Abstracts
Evaluation of Reduced Observation Times for Subcutaneous Administration of Daratumumab and Hyaluronidase in Patients With Multiple Myeloma
Abstract #CR08
Brian Primeaux, PharmD, BCOP; Arsemen Brown, PharmD; Alisha Desai, PharmD; Elizabeth Graver, PharmD; Amy Zheng, PharmD; Sandra Horowitz, PharmD
Read More
HOPA Abstracts
Evaluation of Services Provided by Pharmacists in Addition to Accredited Patient Management Program Responsibilities in a Health-System Specialty Pharmacy
Abstract #CR09
Jeremiah Moore, PharmD, BCOP; Maria Pinto, PharmD; Elizabeth Rightmier, PharmD, BCPS
Read More
HOPA Abstracts
Hematologic Oral Oncolytics: Adherence, Healthcare Cost, and Utilization
Abstract #CR10
Khadijah Khan, CPhT; Francis C. Staskon, PhD; Laly Havern, PharmD; Amy Pfeifer, PharmD, BCPS, CSP
Read More
HOPA Abstracts
Identifying Barriers to Expanded Access Program (EAP) Patient Enrollment in the Hematology/Oncology Community
Abstract #CR12
Jahmal Williams, PharmD, RPh; Claire Groce, PharmD; Madison Henry, PharmD, RPh; Kyle Taylor, PharmD, RPh; Nik Mohan, PharmD; Joseph Barone, PharmD, FCCP, et al.
Read More
HOPA Abstracts
Effect of Clinically Embedded Oncology Pharmacists on Immune Checkpoint Inhibitor Treatment Outcomes
Abstract #CR13
Colton Zwart, PharmD, BCOP; Mark Wagner, PharmD, BCOP; Karen Farris, PhD; David Reyes-Gastelum; Katie Young; Emily Mackler, PharmD, BCOP
Read More
HOPA Abstracts
Effect of Clinically Embedded Pharmacists on the Time of Other Oncology Clinicians
Abstract #CR14
Maja Hill, PharmD; Emily Mackler, PharmD, BCOP; Maisa Nazzal, PharmD, MS; Karen Farris, PhD; Emily Johengen, PharmD, BCACP; Katie Sias, PharmD, BCOP, et al.
Read More
HOPA Abstracts
Effect of Embedded Clinical Pharmacists on Health Utilization Outcomes in a Large Community Oncology Practice
Abstract #CR15
Mark Wagner, PharmD, BCOP; Colton Zwart, PharmD, BCOP; Karen Farris, PhD; David Reyes-Gastelum; Katie Young; Emily Mackler, PharmD, BCOP
Read More
HOPA Abstracts
Improving Oral Anticancer Medication Adherence/Adverse Event Assessment Documentation
Abstract #CR16
Lisa Holle, PharmD, BCOP, FHOPA, FISOPP; Grace Morrison, BS; Andrea Moran, APRN-BC, DNP; Margaret Savage, BSN, RN; Michael K. Keng, MD
Read More
HOPA Abstracts
Managing Oral Anticancer Therapies in Patients With Early or Advanced HR-Positive, HER2-Negative Breast Cancer: A US-based Community Healthcare Provider Survey
Abstract #CR18
Jodi L. Taraba, PharmD, MS, BCOP; Pamela K. Ginex, EdD, MPH, RN, OCN; Qinli Lily Ma, PhD; Kelli Thoele, PhD, RN, OCN; Alexandra S. Vitko, PhD; Astra M. Liepa, PharmD, et al.
Read More
HOPA Abstracts
Safety and Cost Associated With Fixed-Dose Immunotherapy in Patients With Weight Extremes
Abstract #CR19
Christina Davis, PharmD, BCOP; Cali Lunowa, PharmD; Moriah Cargile
Read More
HOPA Abstracts, Venetoclax
Safety and Feasibility of Short-Duration Infusion Obinutuzumab With Venetoclax in Patients With Chronic Lymphocytic Leukemia: A Prospective Observational Study
Abstract #CR20
Matthew Lei, PharmD; Uvette Lou, PharmD; Mark Sorial, PharmD; Brenna Rowen, PharmD; E. Bridget Kim, PharmD; Rana Ruchi, PharmD, et al.
Read More
HOPA Abstracts
Updated Biodistribution and Shedding Analysis of RP1 Oncolytic Immunotherapy From the IGNYTE Clinical Trial: Administration and Handling Implications for Oncology Pharmacists
Abstract #CR21
Christina Davis, PharmD; Caroline Robert, MD, PhD; Michael K. Wong, MD, PhD; Mark R. Middleton, MD, PhD, FRCP; Mohammed M. Milhem, MBBS; Joseph J. Sacco, PhD, FRCP, et al.
Read More
HOPA Abstracts, Venetoclax
Venetoclax and Obinutuzumab in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A 3-Year Follow-Up
Abstract #CR22
Uvette Lou, PharmD, BCOP; Matthew Lei, PharmD, BCOP; Mark Sorial, PharmD, BCOP; Michelle Yu; Andrea Medrano, BS, PharmD Candidate; Jeremy S. Abramson, MD, MS, et al.
Read More
HOPA Abstracts
Smart Solutions: Leveraging Artificial Intelligence in Investigational Drug Services
Abstract #LB01
Travis Smith, PharmD, MBA; Alan Yee, PharmD, MS; Camille Walters, PharmD
Read More
HOPA Abstracts
Evaluating the Value of Clinical Oncology Pharmacists: Time-Savings for Healthcare Providers in The US Oncology Network
Abstract #LB02
Julianne Darling, PharmD, BCOP; Hilary Conkling, PharmD, BCOP; Alexa Basilio, PharmD, BCOP; Brittney Hale, PharmD, BCOP; Dan Kendzierski, PharmD, BCOP; Andrea Roman, PharmD, BCOP, et al.
Read More
HOPA Abstracts
Incorporation of a Statewide Cancer Drug Repository Program Within an Integrated Specialty Pharmacy
Abstract #LB03
Melisa McKendry, RPh, MSEd; Emily Mackler, PharmD, BCOP; Kimberly Melgarejo, PharmD, MHA; Siobhan Norman
Read More
HOPA Abstracts
Choice of Antifungal Prophylaxis and Risk for Invasive Fungal Disease in Patients With Acute Leukemia Receiving Oral Anticancer Therapies With Significant CYP450 Drug Interactions
Abstract #LB04
Matthew Yacobucci, PharmD, BCOP; Zhenzi Hong; Colby Webster; Alexis Gregoire; Ejemen Aigbedion
Read More
HOPA Abstracts
Evaluation of Fam-Trastuzumab Deruxtecan Utilization Among Patients With Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Abstract #LB05
Matt Arango, PharmD, BCOP; Hiba Alzouby, PharmD, BCOP; Ning Jin, MD; Ashish Manne, MBBS; Arjun Mittra, MD; Anne Noonan, MB ChB, PhD
Read More
HOPA Abstracts
Role of CYP2D6 Phenotypes in Doxorubicin-Related Cardiotoxicity
Abstract #LB06
Oksana O. Karpenko, PharmD, RPh, BCPS; Jodi L. Taraba, PharmD, MS, RPh, BCOP; Ross A. Dierkhising, MS; Kristin C. Cole, MS; Corina J. Doleski, PharmD, RPh, BCOP; Karthik V. Giridhar, MD, et al.
Read More
HOPA Abstracts
Implementation of an Oral Oncolytic Monitoring Pilot Program: A Specialty Pharmacist–Led Approach Using the Revised Edmonton Symptom Assessment System
Abstract #LB07
Clarissa Wilkins, PharmD, BCOP; Alexandra Ritenour, PharmD, CSP
Read More
HOPA Abstracts
Pressurized Intraperitoneal Aerosolized Chemotherapy: Operationalizing From a Pharmacy Perspective at a Large Academic Medical Center
Abstract #LB08
Aimee Merkert, PharmD; Megan Hinton, PharmD
Read More